Hormone receptor-positive breast cancers (ER+ and/or PR+) and TNBC exhibit significant differences in their biology, response to treatments, and overall prognosis (Sirhan et al., 2022)
Preliminary results of the neratinib arm in the individualized screening trial of innovative glioblastoma therapy (INSIGhT): a phase II platform trial using Bayesian adaptive randomization
The problem is that these uses are not well studied, and the risks are often not explained
Structural repair continues well past the early-change window, which is why courses are dosed over weeks rather than as a one-time shot
Y.et al
pylori infection by modulating the gastric innate immune response, significantly reducing the levels of TNF-, IL-8, and Monocyte Chemotactic Protein 1 (MCP-1) in the gastric mucosa of infected mice, while increasing the expression of Interferon-gamma (IFN-) and IL-10 (Garcia-Castillo et al., 2020)